Blog

Shaping the Future of Healthcare with Jiva.ai

Shaping the Future of Healthcare with Jiva.ai

Written by Marta Caldeira, 24th September 2020 Founded by Dr Manish Patel and Dr Chetan Kaher in 2019, British startup Jiva.ai is transforming the world of healthcare by providing a much-needed framework for the integration of different artificial intelligence (AI)...

read more
Pear Bio and the Ever-expanding World of Tailored Oncology

Pear Bio and the Ever-expanding World of Tailored Oncology

Written by Oscar Drury, 25th August 2020 In a world reliant upon standard patient care within oncology, Pear Bio looks to reform how pharmaceutical companies trial new drugs in addition to how doctors treat patients. This upheaval of the treatment status quo aims to...

read more
NHSX Precision Medicine Case Study – Prof Phil Beales

NHSX Precision Medicine Case Study – Prof Phil Beales

Precision medicine encompasses predictive, preventive, personalised and participatory medicine (also termed P4 medicine). It is moving from the traditional one-size-fits-all form of medicine to more preventative, personalised, data-driven disease management model that...

read more
P4 2021 Programme Opening

P4 2021 Programme Opening

 PRESS RELEASEJuly 22, 2020 P4 Precision Medicine Accelerator opens 2021 programme applications * Please share with anyone in your network you feel may be interested in applying Powered by Barclays Eagle Labs, the P4 programme curates a unique ecosystem to support...

read more
The journey of ElectronRx

The journey of ElectronRx

  Written by Marta Caldeira, 15th July 2020 Founded by Dr Bipin Patel, ElectronRx is a deep tech company working to develop novel diagnostic and therapeutic tools for the relief of human suffering. These include, among others, tools for the relief of heart failure and...

read more
Motilent & Partners Receive Prestigious UKRI Funding

Motilent & Partners Receive Prestigious UKRI Funding

Crohn’s Disease is a chronic inflammatory condition of the intestine affecting people of all ages. There is an urgent need for technology to guide the use of powerful and expensive anti-inflammatory medications. Motilent has been awarded  a prestigious UKRI grant to...

read more